Cargando…

A Rare Case of Metastatic Transformation to Pituitary Carcinoma

Background: Pituitary carcinomas are rare and comprise less than 0.5% of pituitary tumors and frequently arise from previously resected and/or radiated infiltrating adenomas.(1) Radiation therapy is used to prevent regrowth but does not have significant data supporting improved prognosis.(2) True pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Woznick, Walter K, Engel, Ashley, Maas, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265898/
http://dx.doi.org/10.1210/jendso/bvab048.1153
_version_ 1783719826938658816
author Woznick, Walter K
Engel, Ashley
Maas, Diana
author_facet Woznick, Walter K
Engel, Ashley
Maas, Diana
author_sort Woznick, Walter K
collection PubMed
description Background: Pituitary carcinomas are rare and comprise less than 0.5% of pituitary tumors and frequently arise from previously resected and/or radiated infiltrating adenomas.(1) Radiation therapy is used to prevent regrowth but does not have significant data supporting improved prognosis.(2) True pituitary carcinomas requires the presence of craniospinal and/or systemic metastases. Here, we present a case of benign pituitary adenoma that had progressed to a metastatic tumor and responded to radiation therapy. Clinical Case: Our patient was first diagnosed in 1982 with a pituitary mass after undergoing an MRI due to right eye blindness. He ultimately had a transcranial resection of the tumor and post-operative external radiation to residual tumor. Final pathology was consistent with a nonsecretory tumor. Additionally, he was diagnosed with panhypopituitarism and he was treated accordingly. Due to barriers of patient adherence, only one post-operative MRI was obtained, and he was lost to endocrine follow up. In 2007, he was again referred to endocrinology for new vision loss in the left eye. An MRI revealed a 3.0 x 3.8 x 4.4 cm tumor that compressed the optic chiasm. Additionally, multiple lesions were seen within the dural and leptomeningeal extra-axial areas including the largest left frontal lesion of 2.4 cm and a 1.7 cm lesion posterior to the cord within the foramen magnum. The patient underwent endonasal transsphenoidal resection of the sellar mass and biopsy of the frontal lesion in October 2007. Pathology showed pituitary adenocarcinoma in both the sellar and frontal lesions and immunoperoxidase staining was negative for all hormones. He completed salvage radiation to the sellar and craniospinal lesions in December 2007. MRI scans completed 7 months later showed stable residual pituitary and metastatic lesions. The patient received 6-month MRI screening exams for the first 2 years and then annually thereafter, as well as PET scanning, without significant progression or new metastatic lesions. Conclusion: We present a case of benign pituitary adenoma which transformed following resection to a malignant tumor with metastatic lesions in the brain and spinal cord that was treated with radiation with relative success. Despite the often-aggressive nature of these metastatic tumors, the patient has experienced a successful treatment course with minimal side effects and without progression 13 years after initial treatment of the metastatic pituitary carcinoma.
format Online
Article
Text
id pubmed-8265898
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82658982021-07-09 A Rare Case of Metastatic Transformation to Pituitary Carcinoma Woznick, Walter K Engel, Ashley Maas, Diana J Endocr Soc Neuroendocrinology and Pituitary Background: Pituitary carcinomas are rare and comprise less than 0.5% of pituitary tumors and frequently arise from previously resected and/or radiated infiltrating adenomas.(1) Radiation therapy is used to prevent regrowth but does not have significant data supporting improved prognosis.(2) True pituitary carcinomas requires the presence of craniospinal and/or systemic metastases. Here, we present a case of benign pituitary adenoma that had progressed to a metastatic tumor and responded to radiation therapy. Clinical Case: Our patient was first diagnosed in 1982 with a pituitary mass after undergoing an MRI due to right eye blindness. He ultimately had a transcranial resection of the tumor and post-operative external radiation to residual tumor. Final pathology was consistent with a nonsecretory tumor. Additionally, he was diagnosed with panhypopituitarism and he was treated accordingly. Due to barriers of patient adherence, only one post-operative MRI was obtained, and he was lost to endocrine follow up. In 2007, he was again referred to endocrinology for new vision loss in the left eye. An MRI revealed a 3.0 x 3.8 x 4.4 cm tumor that compressed the optic chiasm. Additionally, multiple lesions were seen within the dural and leptomeningeal extra-axial areas including the largest left frontal lesion of 2.4 cm and a 1.7 cm lesion posterior to the cord within the foramen magnum. The patient underwent endonasal transsphenoidal resection of the sellar mass and biopsy of the frontal lesion in October 2007. Pathology showed pituitary adenocarcinoma in both the sellar and frontal lesions and immunoperoxidase staining was negative for all hormones. He completed salvage radiation to the sellar and craniospinal lesions in December 2007. MRI scans completed 7 months later showed stable residual pituitary and metastatic lesions. The patient received 6-month MRI screening exams for the first 2 years and then annually thereafter, as well as PET scanning, without significant progression or new metastatic lesions. Conclusion: We present a case of benign pituitary adenoma which transformed following resection to a malignant tumor with metastatic lesions in the brain and spinal cord that was treated with radiation with relative success. Despite the often-aggressive nature of these metastatic tumors, the patient has experienced a successful treatment course with minimal side effects and without progression 13 years after initial treatment of the metastatic pituitary carcinoma. Oxford University Press 2021-05-03 /pmc/articles/PMC8265898/ http://dx.doi.org/10.1210/jendso/bvab048.1153 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Woznick, Walter K
Engel, Ashley
Maas, Diana
A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title_full A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title_fullStr A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title_full_unstemmed A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title_short A Rare Case of Metastatic Transformation to Pituitary Carcinoma
title_sort rare case of metastatic transformation to pituitary carcinoma
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265898/
http://dx.doi.org/10.1210/jendso/bvab048.1153
work_keys_str_mv AT woznickwalterk ararecaseofmetastatictransformationtopituitarycarcinoma
AT engelashley ararecaseofmetastatictransformationtopituitarycarcinoma
AT maasdiana ararecaseofmetastatictransformationtopituitarycarcinoma
AT woznickwalterk rarecaseofmetastatictransformationtopituitarycarcinoma
AT engelashley rarecaseofmetastatictransformationtopituitarycarcinoma
AT maasdiana rarecaseofmetastatictransformationtopituitarycarcinoma